Pharmafile Logo

EphMRA Annual Conference 2018

Visit us on stand number 20

We are delighted to be presenting, exhibiting and sponsoring the EphMRA Annual Conference in Basel, on 26-28 June. Representing Research Partnership at the event are Senior Director Angela Duffy, Director Richard Head, and Associate Director An-hwa Lee.

On Wednesday 27th June from 10.10 – 10.40 following the opening Keynote, Ursula Kraus-Meeder from Boehringer Ingelheim and Angela Duffy will be presenting the paper ‘How researchers became journalists to champion the voice of the customer’. In this paper, Ursula and Angela will show how they worked together on an initiative which would challenge the  BI team’s comfort levels and capabilities, but ultimately elevate customer insights to a broader and more senior audience within the wider organisation.

Find out more: https://www.researchpartnership.com/news/2018/05/ephmra-annual-conference-2018/

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcertâ„¢ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcertâ„¢, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

What to expect from Obesity Week 2025: Key trends shaping the future of obesity care

Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.

AI with intent: How Inizio is redefining pharma through precision and partnership

At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...

Leading the future of Intelligent Commercializationâ„¢: Where proprietary data, tech, and AI meet expert insight

Inizio is leading the way in Intelligent Commercializationâ„¢ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.

Delivering purposeful solutions at Obesity Week 2025

We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

Inizio strengthens executive team with new leadership appointments

Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercializationâ„¢...